DA32 Sponsor LLC - Jul 27, 2021 Form 3 Insider Report for DA32 Life Science Tech Acquisition Corp. (DALS)

Role
10%+ Owner
Signature
/s/ Henrikki Harsu, Attorney-in-Fact for DA32 Sponsor LLC
Stock symbol
DALS
Transactions as of
Jul 27, 2021
Transactions value $
$0
Form type
3
Date filed
7/27/2021, 08:14 PM
Next filing
Aug 3, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DALS Class B Common Stock Jul 27, 2021 Class A Common Stock 5.17M Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Class B Common Stock are convertible for shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-257679) (the "Registration Statement") and have no expiration date. The shares of Class B Common Stock beneficially owned by the Reporting Persons include up to 750,000 shares of Class B Common Stock subject to forfeiture to the Issuer depending on the extent to which the underwriters' over-allotment option is exercised in connection with the Issuer's initial public offering of Class A Common Stock, as described in the Registration Statement.
F2 DA32 Sponsor LLC is the record holder of the securities reported herein. Deerfield Partners, L.P., ARCH Venture Fund XI, L.P. and Section 32 Fund 3, LP are the managing members of DA32 Sponsor LLC, and share voting and investment discretion with respect to the common stock held of record by DA32 Sponsor LLC. Each of the foregoing entities disclaim beneficial ownership of these shares except to the extent of any pecuniary interest therein.

Remarks:

See Exhibit 24.1 - Power of Attorney.